EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH)

LIVE

Serial Number

99001424

Owner

Foundation for Advancing Science, Technology, Education and Research

First Use Date

Jan 15, 2025

Filing Date

Jan 16, 2025

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH) Trademark

Serial Number: 99001424 • Registration: 8018739

EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH (ENRICH) is a trademark filed by Foundation for Advancing Science, Technology, Education and Research on January 16, 2025. The trademark is classified under Class 35 (Advertising & Business). The application is currently registered and active.

Trademark Classes

Class 35 - Advertising & Business

Advertising; business management; business administration; office functions

Owner Contact Info

Foundation for Advancing Science, Technology, Education and Research (2 trademarks)

3000 Riverchase Galleria
Hoover, AL 35244

Entity Type: 03

Legal Representation

Correspondence Address

Foundation for Advancing Science, Technology, Education and Research

3000 Riverchase Galleria

Suite 755

Hoover, AL 35244

United States

Trademark Details

Filing Date

January 16, 2025

Registration Date

November 11, 2025

First Use Anywhere

January 15, 2025

First Use in Commerce

January 15, 2025

Published for Opposition

September 23, 2025

Goods & Services

Association services, namely, promoting the interests of healthcare providers and researchers

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Nov 11, 2025 NRCC

REGISTERED-PRINCIPAL REGISTER

Nov 11, 2025 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Sep 23, 2025 NPUB

PUBLISHED FOR OPPOSITION

Sep 23, 2025 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Sep 17, 2025 NONP

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 22, 2025 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 21, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2025 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 20, 2025 ERFR

NOTIFICATION OF SUBSEQUENT FINAL EMAILED

Aug 19, 2025 GNS1

CONTINUATION OF FINAL REFUSAL E-MAILED

Aug 19, 2025 GNCF

ACTION CONTINUING A FINAL - COMPLETED

Aug 19, 2025 CNCF

TEAS/EMAIL CORRESPONDENCE ENTERED

Jul 21, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jul 21, 2025 CRFA

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Jul 21, 2025 ERFR

NOTIFICATION OF FINAL REFUSAL EMAILED

Jul 11, 2025 GNFN

FINAL REFUSAL E-MAILED

Jul 11, 2025 GNFR

FINAL REFUSAL WRITTEN

Jul 11, 2025 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Jun 27, 2025 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Jun 27, 2025 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Jun 27, 2025 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 26, 2025 GNRN

NON-FINAL ACTION E-MAILED

Jun 26, 2025 GNRT

NON-FINAL ACTION WRITTEN

Jun 26, 2025 CNRT

ASSIGNED TO EXAMINER

Jun 25, 2025 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 17, 2025 NWOS

NEW APPLICATION ENTERED

Jan 16, 2025 NWAP

Related Trademarks

More from this Owner

ENRICH EXCELLENCE NETWORK IN RHEUMATOLOGY TO INNOVATE CARE AND HIGH-IMPACT RESEARCH

ENRGY EXCELLENCE NETWORK IN RHEUMATOLOGY

More in Same Class

Serial #99000159

THE LAST SERVICE SEARCH YOU WILL EVER NEED

YOONSEUL

KINO GLASS

LONDON NOOTROPICS

TRUBRAND MARKETING